Procurement & Operations

Choosing an amniotic graft supplier for a private practice

Supplier selection for amniotic membrane allografts affects clinical outcomes, billing integrity, and operational reliability. This guide outlines the criteria a private wound-care practice should use to evaluate a supplier.

By Kindr Clinical Editorial TeamMedically reviewed by Reviewer pending — EDIT ME, Healthcare compliance attorney + practice manager (engagement pending)Last reviewed: 2026-06-28

Direct answer

Supplier selection for amniotic membrane allografts affects clinical outcomes, billing integrity, and operational reliability. This guide outlines the criteria a private wound-care practice should use to evaluate a supplier.

The criteria that matter

Supplier selection should be evaluated against a defined criteria set rather than a single price comparison. The following criteria are commonly used by wound-care practice managers and are organized from highest to lowest weight in most evaluations:

1. Regulatory and quality posture

  • Supplier (or its tissue processor) is FDA-registered as an HCT/P establishment [1]
  • Product is correctly classified under 21 CFR 1271 [2]
  • Current Good Tissue Practice (cGTP) compliance is documented
  • Certificate of analysis available on request per lot
  • Adverse event reporting and recall procedures are documented and tested

2. Product evidence and labeling

  • Clear instructions for use covering indication, application, and storage
  • Published clinical evidence (or transparent acknowledgement of evidence limitations)
  • Lot-level documentation including donor eligibility per 21 CFR 1271 Subpart C
  • Product specifications match the package insert

3. Billing alignment

  • Current HCPCS Q-code mapping provided and updated quarterly with the CMS HCPCS file [3]
  • Clear documentation of unit of measure and per-cm² pricing
  • No bundling or "marketing program" arrangements that could implicate the federal anti-kickback statute or trigger Stark/OIG concerns [4]

This criterion is non-negotiable. A supplier that proposes any payment, rebate, free product, or service in a way that could be characterized as remuneration in exchange for ordering should be declined, regardless of price. Practices remain liable for downstream billing even if a supplier suggests the arrangement is permissible.

4. Operational reliability

  • Order lead time and fulfillment rate
  • Shipping infrastructure (cold-chain for cryopreserved product)
  • Clear return/credit policy for damaged or expired product
  • Responsive operational support contact (not just a sales rep)

5. Pricing transparency

  • Published or quoted per-size, per-cm² pricing
  • No undisclosed fees or "rebate" arrangements
  • Tokenized quote workflows (such as the one on this site) that preserve a written record of the agreed price

What to ask in a supplier evaluation

  • Provide your FDA establishment registration number
  • Provide a current package insert and the most recent certificate of analysis lot
  • Provide the current HCPCS Q-code mapping and the date of the underlying HCPCS update
  • Describe your adverse event reporting and recall process
  • Describe your cold-chain process if applicable
  • Provide standard payment terms in writing

Red flags

  • Refusal or delay in providing FDA registration or product documentation
  • Pricing that varies by reimbursement collected (a strong anti-kickback red flag)
  • Free product offered in exchange for committed volume above ordinary trade discount
  • Pressure to use the supplier''s own billing templates or to bill in a specific way

How this site fits

This site is operated as a no-login distributor: clinicians browse the catalog, request a quote, and receive a tokenized quote by email. Account setup is minimal; pricing is shown in the quote; reorders clone prior quotes. The model removes the traditional sales-rep paperwork cycle and the implicit pressure dynamics that follow from rep-led ordering.

  • How to order amniotic grafts online
  • Amniotic allograft Q-codes: a clinician reference
  • Compliance overview (see /compliance)

Sources

  1. [1] FDA, Establishment Registration & Listing for HCT/Ps
  2. [2] FDA, 21 CFR Part 1271
  3. [3] CMS, HCPCS Quarterly Update files
  4. [4] HHS OIG, Anti-Kickback Statute resources

Browse the catalog →

Amniotic grafts, instruments, consumables, post-op supplies.

Request a quote →

No login. Secure tokenized quote sent by email.

Graft sizing tool →

Right-size grafts to reduce unused tissue.

More resources →

Billing, clinical, and procurement library.

This article is educational and does not constitute medical, billing, or legal advice. Verify all coding, coverage, and clinical decisions against current payer policy and your institution's protocols.